Efficacy and safety of praziquantel for the treatment of human schistosomiasis during pregnancy: a p...
Efficacy and safety of praziquantel for the treatment of human schistosomiasis during pregnancy: a phase 2, randomised, double-blind, placebo-controlled trial
About this item
Full title
Author / Creator
Olveda, Remigio M, MD , Acosta, Luz P, PhD , Tallo, Veronica, PhD , Baltazar, Palmera I, MD , Lesiguez, Jenny Lind S, MD , Estanislao, Georgette G, MD , Ayaso, Edna B, MD , Monterde, Donna Bella S, MD , Ida, Antonio, MD , Watson, Nora, PhD , McDonald, Emily A, PhD , Wu, Hannah W, PhD , Kurtis, Jonathan D, Prof and Friedman, Jennifer F, Prof
Publisher
United States: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
United States: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
Summary Background Despite WHO recommendations to offer pregnant women treatment with praziquantel, many nations continue to withhold treatment, awaiting data from controlled trials addressing safety and efficacy. The objectives of this study were to assess whether treatment of pregnant women with schistosomiasis at 12–16 weeks gestation leads to i...
Alternative Titles
Full title
Efficacy and safety of praziquantel for the treatment of human schistosomiasis during pregnancy: a phase 2, randomised, double-blind, placebo-controlled trial
Authors, Artists and Contributors
Author / Creator
Acosta, Luz P, PhD
Tallo, Veronica, PhD
Baltazar, Palmera I, MD
Lesiguez, Jenny Lind S, MD
Estanislao, Georgette G, MD
Ayaso, Edna B, MD
Monterde, Donna Bella S, MD
Ida, Antonio, MD
Watson, Nora, PhD
McDonald, Emily A, PhD
Wu, Hannah W, PhD
Kurtis, Jonathan D, Prof
Friedman, Jennifer F, Prof
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_1762458195
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1762458195
Other Identifiers
ISSN
1473-3099
E-ISSN
1474-4457
DOI
10.1016/S1473-3099(15)00345-X
